EarningsQ4 2021 Earnings Report

Wuxi Biologics (Cayman) (2269N) Q4 2021 Earnings Report

0 Followers

MX:2269N Q4 2021 EPS Results

Actual EPS$0.99

Consensus EPS$6.29

Beat/MissMissed by -$5.30

One Year Ago EPS$0.63

Actual Revenue$16.32B

Expected Revenue$99.88B

Beat/MissMissed by -$83.56B

YoY Revenue Growth+69.64%

QuarterQ4 2021

Date03/22/2022

TimeBefore Open

Conference CallTuesday, March 22, 2022

MX:2269N Upcoming Earnings

Wuxi Biologics (Cayman)'s next earnings date is estimated for March 23, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 23, 2027	2026 (Q4)	1.94 / -	1.559	―
Aug 25, 2026	2026 (Q2)	1.21 / 1.55	1.474	5.45% (+0.08)
Mar 24, 2026	2025 (Q4)	1.69 / 1.56	0.516	202.22% (+1.04)
Aug 19, 2025	2025 (Q2)	1.21 / 1.47	0.938	57.14% (+0.54)
Mar 25, 2025	2024 (Q4)	1.18 / 0.60	0.699	-13.79% (-0.10)
Aug 21, 2024	2024 (Q2)	1.10 / 0.94	1.739	-46.07% (-0.80)
Mar 26, 2024	2023 (Q4)	0.72 / 0.70	1.176	-40.55% (-0.48)
Aug 23, 2023	2023 (Q2)	1.10 / 1.74	1.551	12.09% (+0.19)
Mar 22, 2023	2022 (Q4)	1.07 / 1.18	0.991	18.65% (+0.18)
Aug 17, 2022	2022 (Q2)	10.59 / 1.55	1.125	37.86% (+0.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed